Study of amrapallava taila in the management of karnasrava

Randomised control study of amrapallava taila in the management of karnasrava with special reference to otomycosis

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021448

Enrollment

Registered

2019-09-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H603- Other infective otitis externa

Interventions

Intervention1: Amrapallava taila karnapoorana in karnasrava : Amrapallava taila karnapoorana 8 to 10drops for 2 minits Control Intervention1: 1% clotrimazole ear drop 2to 3 drops: 1% clotrimazole ea

Eligibility

Inclusion criteria

Inclusion criteria: Patient between age 18 to 60 years of both sex shows classical sings and symptoms of karnasrava otomycosis patient having fungal mass and debris in external auditory canal

Exclusion criteria

Exclusion criteria: patient suffering from systemic disease like diabetic tuberculosis patient age below 18 years and above 60 years patient having perforated tympanic memebrane pathology for example acute suppurative otitis media and chronic suppurative otitis media patient with having malignant otitis externa

Design outcomes

Primary

Measure	Time frame
To study the efficacy of Amrapallva tail in karnasravaTimepoint: 18 months	—

Secondary

Measure	Time frame
To study the mode of action of amrapallava tailaTimepoint: 10 days	—

Countries

India

Contacts

Public Contactdr Monish Rangate

annasaheb dange ayurved medical college ashta

dr.monishrangate@gmail.com9923429223

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026